메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background/Aims: α-Fetoprotein (AFP) is the biomarkermost widely used to detect hepatocellular carcinoma (HCC),despite its suboptimal diagnostic accuracy. Glypican-3 (GPC3)and osteopontin (OPN) are secreted glycoproteins that are reportedlyassociated with tumorigenesis and metastasis. Thisstudy was conducted to evaluate the clinical utility of usingplasma GPC3 and OPN as diagnostic biomarkers for HCC. Methods: We measured the plasma levels of GPC3 and OPNin 120 HCC and 40 chronic liver disease (CLD) patients viaan enzyme-linked immunosorbent assay. The diagnostic accuracyof each tumor marker was evaluated using receiveroperating characteristic (ROC) curve analysis. Results: TheGPC3 levels in the HCC patients (75.8 ng/mL) were significantlyhigher (p=0.020) than the levels in patients withCLD (66.4 ng/mL). The area under the ROC curve (AUROC)values for GPC3 and OPN were 0.62 and 0.51, respectively. In subgroup analyses, including subgroups of HCC patientswith low serum AFP and PIVKA II levels, the AUROC of GPC3remained relatively high (0.66), and GPC3 showed a highsensitivity (62.1%) for detecting small HCC tumors. Conclusions:The plasma levels of GPC3 and OPN demonstratedlow diagnostic accuracy for HCC. However, GPC3 may havea complementary role in diagnosing HCC in patients withnondiagnostic levels of conventional tumor markers and withsmall-sized tumors.

목차

등록된 정보가 없습니다.

참고문헌 (25)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0